Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of l-ornithine and l-aspartate, amino acids that play a role in the urea cycle and ammonia detoxification.
## Primary Indications
* Treatment of latent and overt hepatic encephalopathy in patients with liver cirrhosis.
## Adult Dosing
* **Hepatic Encephalopathy:** Typically administered intravenously. Common starting doses are 10-20 grams per day, divided into 2-3 infusions. Some sources suggest doses up to 30 grams per day, divided, may be used for severe cases. The exact dosing and duration depend on the severity of encephalopathy and patient response, often guided by local protocol.
## Pediatric Dosing
* Data regarding the use of l-ornithine l-aspartate in pediatric patients is limited. Use in children should be under the strict supervision of a healthcare professional, with dosing based on individual clinical assessment and available evidence, which is often extrapolated from adult data or small studies.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are typically recommended in the package insert for mild to moderate renal impairment, as the drug is metabolized and excreted primarily through the liver. However, caution is advised, and monitoring of ammonia levels is important.
* **Hepatic Impairment:** The drug is intended for patients with hepatic impairment.
## Contraindications
* Severe kidney disease.
* Known hypersensitivity to l-ornithine or l-aspartate.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal discomfort, diarrhea, flatulence, bloating.
* **Less Common:** Dizziness, headache, fatigue, muscle weakness.
* **Rare:** Allergic reactions.
## Key Drug Interactions
* No significant drug interactions are well-established. However, concurrent use of other medications affecting ammonia levels or liver function should be closely monitored.
## Monitoring
* Clinical signs and symptoms of hepatic encephalopathy (e.g., mental status changes, asterixis).
* Serum ammonia levels.
* Renal and liver function tests.
## Clinical Pearls
* Hepamerz aims to reduce elevated ammonia levels by promoting its detoxification through the urea cycle (ornithine) and by stimulating glutamine synthesis and excretion (aspartate).
* It is often administered as an intravenous infusion, and the rate of infusion should be managed to minimize gastrointestinal side effects.
* Treatment duration is variable and depends on the clinical response and the underlying liver condition.
***
**Disclaimer:** This information is intended for clinical professionals. Always consult the most current prescribing information and relevant literature for complete details and to verify accuracy before making clinical decisions.
